Large-scale testing (Phase 3)UnknownNCT01654146What this trial is testingICON8: Weekly Chemotherapy in Ovarian CancerWho this might be right forOvarian Cancer Medical Research Council 1,485
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816666What this trial is testingTorvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian CancerWho this might be right forPlatinum-sensitive Relapsed Epithelial Ovarian CancerPlatinum-sensitive Relapsed Fallopian Tube CancerPlatinum-sensitive Relapsed Primary Peritoneal Cancer AstraZeneca 600
Large-scale testing (Phase 3)Study completedNCT00976911What this trial is testingAURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian CancerWho this might be right forOvarian Cancer Hoffmann-La Roche 361
Early research (Phase 1)Looking for participantsNCT04811703What this trial is testingPressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian CancerWho this might be right forMetastatic Ovarian CarcinomaPeritoneal CarcinomatosisStage III Ovarian Cancer+4 more Hospices Civils de Lyon 15
Testing effectiveness (Phase 2)UnknownNCT02562365What this trial is testingAdjuvant Chemotherapy of Three-step Regimen in Ovarian CancerWho this might be right forOvarian Cancer Xiaohua Wu MD 130
Early research (Phase 1)Study completedNCT00004082What this trial is testingCombination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial TumorsWho this might be right forEndometrial CancerFallopian Tube CancerOvarian Cancer+1 more Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Study completedNCT00390234What this trial is testingZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaWho this might be right forFallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more National Cancer Institute (NCI) 63
Very early researchActive Not RecruitingNCT05415709What this trial is testingHyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal CancerWho this might be right forFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous Adenocarcinoma+30 more Ohio State University Comprehensive Cancer Center 35
Very early researchStudy completedNCT02111941What this trial is testingVaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more Mayo Clinic 19
Testing effectiveness (Phase 2)Ended earlyNCT00522301What this trial is testingSorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second RemissionWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center 6
Large-scale testing (Phase 3)WithdrawnNCT00693342What this trial is testingVaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete RemissionWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Large-scale testing (Phase 3)Study completedNCT00028743What this trial is testingCombination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer NCIC Clinical Trials Group 819
Testing effectiveness (Phase 2)UnknownNCT00003160What this trial is testingWeekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and PlatinumWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Theradex 100
Large-scale testing (Phase 3)Study completedNCT02477644What this trial is testingPlatine, Avastin and OLAparib in 1st LineWho this might be right forOvarian Cancer Arcagy Research 806
Early research (Phase 1)Study completedNCT00021034What this trial is testingTaurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT03693248What this trial is testingReduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal CancerWho this might be right forOvarian Cancer Stage IIICOvarian Cancer Stage IVFallopian Tube Cancer+1 more Seoul National University Hospital 298
Large-scale testing (Phase 3)Looking for participantsNCT04111978What this trial is testingMAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)Who this might be right forOvarian Neoplasm EpithelialFallopian Tube NeoplasmsPeritoneal Neoplasms+3 more Swiss GO Trial Group 540
Not applicableUnknownNCT01074398What this trial is testingBiomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182Who this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Gynecologic Oncology Group 513
Testing effectiveness (Phase 2)Study completedNCT00059787What this trial is testingErlotinib Plus Carboplatin and Paclitaxel in Ovarian CarcinomaWho this might be right forBrenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+6 more National Cancer Institute (NCI) 56